IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 174 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.11 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $23,986,000 | -29.8% | 757,621 | +2.8% | 0.04% | -32.8% |
| Q4 2020 | $34,180,000 | +43.9% | 736,630 | +2.1% | 0.06% | +24.5% |
| Q3 2020 | $23,756,000 | +23.4% | 721,632 | +2.9% | 0.05% | +8.9% |
| Q2 2020 | $19,256,000 | -3.7% | 701,477 | +5.0% | 0.04% | -26.2% |
| Q1 2020 | $19,994,000 | +8.6% | 667,898 | +0.5% | 0.06% | +29.8% |
| Q4 2019 | $18,404,000 | +60.0% | 664,852 | +5.2% | 0.05% | +46.9% |
| Q3 2019 | $11,501,000 | – | 631,971 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,876,600 | $127,618,000 | 11.48% |
| Fairmount Funds Management LLC | 596,890 | $19,650,000 | 8.32% |
| Ghost Tree Capital, LLC | 575,000 | $18,929,000 | 5.47% |
| Perceptive Advisors | 10,085,632 | $332,019,000 | 4.85% |
| Avoro Capital Advisors LLC | 9,536,039 | $313,926,000 | 4.46% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $43,224,000 | 3.88% |
| ACUTA CAPITAL PARTNERS, LLC | 315,000 | $10,370,000 | 2.82% |
| Orbimed Advisors | 6,645,100 | $218,757,000 | 2.75% |
| QVT Financial LP | 572,971 | $18,862,000 | 2.30% |
| Prosight Management, LP | 120,606 | $3,970,000 | 1.89% |